Acadia is trailblazing breakthroughs in neuroscience to elevate life. Therapeutic areas of focus include Parkinson’s disease psychosis, Alzheimer’s disease psychosis, Rett syndrome, and negative symptoms of schizophrenia.
Acadia peer-reviewed scientific publications developed in collaboration with leading global clinical scientists and healthcare professionals.
Our team of medical and scientiﬁc professionals are committed to providing timely and accurate information in response to unsolicited requests, to make informed clinical decisions for patients.
Report Adverse Event: If you have an adverse event or product complaint to report, please contact Acadia Pharmaceuticals Inc. at 1-844-422-2342, or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.